Hepatitis C-vírus-fertozés kiújulása májátültetés után. Mi változott az elmúlt 10 évben?

Translated title of the contribution: Hepatitis C virus recurrence after liver transplantation in Hungary. Trends over the past 10 years

Fanni Gelley, György Gámán, Zsuzsanna Gerlei, Gergely Zádori, Dénes Görög, László Kóbori, Imre Fehérvári, János Schuller, László Szonyi, Péter Nagy, Attila Doros, János Fazakas, Gabriella Lengyel, Zsuzsa Schaff, András Kiss, Eniko Sárváry, Balázs Nemes

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: Management of hepatitis C virus recurrence is a challenge after liver transplantation. Aim: The aim of the authors was to analyse the outcome of liver transplantation performed in hepatitis C virus positive patients during the past ten years and to compare recent data with a previous report of the authors. Method: The authors retrospectively evaluated the data (donors, recipients, perioperative characteristics, patient and graft survival, serum titer of hepatitis C virus RNA, histology) of 409 patients who underwent liver transplantation between 2003 and 2012. Results: 156 patients were transplanted due to hepatitis C virus associated liver cirrhosis (38%). Worse outcome was observed in these patients in comparison to hepatitis C virus negative recipients. The cumulative patient survival rates at 1, 5, and 10 year were 80%, 61%, 51% in the hepatitis C virus positive group and 92%, 85%, 79% in the hepatitis C virus negative group, respectively (p<0.001). The cumulative graft survival rates at 1, 5 and 10 year were 79%, 59% and 50% in hepatitis C virus positive and 89%, 80% and 70% in hepatitis C virus negative patients (p<0.001). Hepatitis C virus recurrence was observed in the majority of the patients (132 patients, 85%), mainly within the first year (83%). The authors observed recurrence within 6 months in 71 patients (56%), and within 3 months in 26 patients (20%). The mean hepatitis C virus recurrence free survival was 243 days. Higher rate of de novo diabetes was detected in case of early recurrence. The cumulative patient survival rates at 1, 3, 5, 10 years were 98%, 89.5%, 81% and 65% when hepatitis C virus recurrence exceeded 3 months and 64%, 53%, 30.5% and 30.5% in patients with early recurrence (p<0.001). Conclusions: Poor outcome of liver transplantation in hepatitis C virus positive patients is still a challenge. Hepatitis C virus recurrence is observed earlier after liver transplantation in comparison with a previous report of the authors. De novo diabetes occurs more frequently in case of early recurrence. Despite an immediate start of antiviral treatment, early recurrence has a significant negative impact on the outcome of transplantation.

Original languageHungarian
Pages (from-to)1058-1066
Number of pages9
JournalOrvosi hetilap
Volume154
Issue number27
DOIs
Publication statusPublished - Jul 1 2013

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gelley, F., Gámán, G., Gerlei, Z., Zádori, G., Görög, D., Kóbori, L., Fehérvári, I., Schuller, J., Szonyi, L., Nagy, P., Doros, A., Fazakas, J., Lengyel, G., Schaff, Z., Kiss, A., Sárváry, E., & Nemes, B. (2013). Hepatitis C-vírus-fertozés kiújulása májátültetés után. Mi változott az elmúlt 10 évben? Orvosi hetilap, 154(27), 1058-1066. https://doi.org/10.1556/OH.2013.29647